npub13us8dx3eaa9x4am506elrml8tjlw3v54cfwmr8sx7p3al97gxqvs5uqafs (npub13us…qafs) npub1vu7uztz0rtxpejd095nl7k78kangchcu58s7cpnt05un5l2n9rsshgnmuv (npub1vu7…nmuv) npub1psdfxfpxz2cwmmnsk60y3nqpn2tqh9n24h4hstvfkwvr6eaek9js499sr7 (npub1psd…9sr7)
I think the exorbitant salary packages to the corporate heads is likely a bigger negative revenue. Companies also get tax write offs, public money to research and public research for free for commercialization. If you count executive compensation & perks, you'll find the bigger drains there. Most pharmaceutical companies also give big dividends, which means they need to generate constant or increasing/predictable profits (overcharging) which also have to come from pts
Nobody باچیز नास्ति (he/him) /
npub10f…r6zca
2023-12-21 11:55:44
in reply to nevent1q…7p3n
Author Public Key
npub10ft9p2a250k500g0qfyteknrnnc5y3eg632resq4xp27t46vcdksar6zcaPublished at
2023-12-21 11:55:44Event JSON
{
"id": "f03e1d61959fd163ac358d088c3682ba60d56c8edcaec6bb8b31f397cc3864b5",
"pubkey": "7a5650abaaa3ed47bd0f0248bcda639cf1424728d4543cc0153055e5d74cc36d",
"created_at": 1703159744,
"kind": 1,
"tags": [
[
"p",
"8f20769a39ef4a6af7747eb3f1efe75cbee8b295c25db19e06f063df97c83019",
"wss://relay.mostr.pub"
],
[
"p",
"673dc12c4f1acc1cc9af2d27ff5bc7b7668c5f1ca1e1ec066b7d393a7d5328e1",
"wss://relay.mostr.pub"
],
[
"p",
"0c1a93242612b0edee70b69e48cc019a960b966aadeb782d89b3983d67b9b165",
"wss://relay.mostr.pub"
],
[
"p",
"22f0ad8bbb4938c0048c4b0a949822ae872382454fafc27dd97b750bbe43a613",
"wss://relay.mostr.pub"
],
[
"p",
"59439741ab2e03f52776ae1eb8f934dfc38cb4fcf8e83c26e12354e7d175fc3e",
"wss://relay.mostr.pub"
],
[
"p",
"27712568050f479dd1204aa1126ca6b1917b59ee54b1a8f51f84fea4ec9785e7",
"wss://relay.mostr.pub"
],
[
"e",
"07884a0831099383c9803a2af159d6ff86014687cb7ecef109074caaf6ee2b80",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://mastodon.social/users/tadbithuman/statuses/111618276986684667",
"activitypub"
]
],
"content": "nostr:npub13us8dx3eaa9x4am506elrml8tjlw3v54cfwmr8sx7p3al97gxqvs5uqafs nostr:npub1vu7uztz0rtxpejd095nl7k78kangchcu58s7cpnt05un5l2n9rsshgnmuv nostr:npub1psdfxfpxz2cwmmnsk60y3nqpn2tqh9n24h4hstvfkwvr6eaek9js499sr7 \nI think the exorbitant salary packages to the corporate heads is likely a bigger negative revenue. Companies also get tax write offs, public money to research and public research for free for commercialization. If you count executive compensation \u0026 perks, you'll find the bigger drains there. Most pharmaceutical companies also give big dividends, which means they need to generate constant or increasing/predictable profits (overcharging) which also have to come from pts",
"sig": "48d17e668945ce97b304be1a615e1b6eb4fe81aa685a621f78a58c5bc42ef7fe1257232316b3e2060ba25ce08f8e31df530904f4b01e312fea8f8ae03a750a5d"
}